AI could outsmart bacteria: a smarter way to choose antibiotics?

NCT ID NCT07762378

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tests whether a machine-learning system called iAST® can improve how doctors choose antibiotics for patients with pneumonia, urinary tract infections, or sepsis. The AI predicts which antibiotics are likely to work before standard lab results are available. Researchers will compare outcomes between patients treated before and after the AI tool is introduced, looking at recovery, complications, and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A machine-learning decision support system (iAST®) that recommends antibiotics before lab results are known
What this could lead to
If effective, this AI tool could help doctors choose the right antibiotics faster, improving recovery and reducing complications in serious infections.
What could go wrong
The study is not randomized and compares before/after groups, so results may be influenced by other factors. The tool's recommendations may not always match the best treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOODSTREAM INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.